Prevalence of antipsychotic polypharmacy in patients with schizophrenia and other psychotic disorders in the MENAT and EMRO countries: a systematic review and meta-analysis. [PDF]
Alhassan MA +7 more
europepmc +1 more source
Identifying Clinical Characteristics of Young People with Treatment-Resistant Schizophrenia Undergoing Community Initiation of Clozapine. [PDF]
Conaty O +5 more
europepmc +1 more source
Clozapine-Associated Neutropenia among People on Clozapine in Japan: A Nationally Representative Retrospective Cohort Study. [PDF]
Trott M +5 more
europepmc +1 more source
Cariprazine augmentation for negative symptoms of schizophrenia: a prospective analysis and literature review. [PDF]
Okon-Rocha E, Taylor D.
europepmc +1 more source
A Clozapine-Responsive GPCR-Based Gene Switch for Pharmacological Control of Gene Expression in Mammalian Cells and In Vivo. [PDF]
Chen G, Li S, Bai P.
europepmc +1 more source
A Case of Clozapine Toxicity Caused by Infection in a Patient with Treatment-Resistant Schizophrenia. [PDF]
Tomita T +3 more
europepmc +1 more source
Adjunctive xanomeline/trospium in clozapine-resistant schizophrenia: two case reports demonstrating limited response. [PDF]
Dang VM, Powers JM, Markota M, Leung JG.
europepmc +1 more source
Cutaneous Small Vessel Vasculitis Secondary to Clozapine Use in a 22-Year-Old Man With Treatment-Resistant Schizophrenia. [PDF]
Ravindran KO +3 more
europepmc +1 more source
Magnetic resonance texture alterations in the caudate nucleus following 18 weeks of clozapine treatment in patients with treatment-resistant schizophrenia. [PDF]
Jo W +8 more
europepmc +1 more source

